8,290 LeMaitre Vascular, Inc. $LMAT Shares Purchased by Vest Financial LLC

Vest Financial LLC boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 10.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 85,152 shares of the medical instruments supplier’s stock after buying an additional 8,290 shares during the period. Vest Financial LLC’s holdings in LeMaitre Vascular were worth $7,033,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Bank of America Corp DE acquired a new stake in shares of LeMaitre Vascular in the 2nd quarter worth $13,524,000. Legal & General Group Plc purchased a new stake in shares of LeMaitre Vascular in the second quarter valued at about $4,840,000. The Manufacturers Life Insurance Company purchased a new stake in shares of LeMaitre Vascular in the second quarter valued at about $1,047,000. Corient Private Wealth LP acquired a new position in shares of LeMaitre Vascular during the second quarter worth about $2,458,000. Finally, Conestoga Capital Advisors LLC increased its stake in shares of LeMaitre Vascular by 3.6% during the first quarter. Conestoga Capital Advisors LLC now owns 1,476,813 shares of the medical instruments supplier’s stock worth $161,224,000 after acquiring an additional 51,825 shares during the period. 84.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on LMAT shares. Wells Fargo & Company reduced their price objective on shares of LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 5th. Wall Street Zen cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings raised LeMaitre Vascular from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Citigroup reissued a “market outperform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 21st. Finally, Zacks Research lowered LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, LeMaitre Vascular currently has an average rating of “Hold” and an average target price of $110.60.

LeMaitre Vascular Stock Performance

NASDAQ LMAT opened at $85.33 on Friday. The company has a quick ratio of 13.96, a current ratio of 16.31 and a debt-to-equity ratio of 0.40. LeMaitre Vascular, Inc. has a fifty-two week low of $78.22 and a fifty-two week high of $118.01. The business has a fifty day moving average of $81.03 and a 200-day moving average of $93.41. The stock has a market cap of $1.95 billion, a price-to-earnings ratio of 30.76, a price-to-earnings-growth ratio of 2.41 and a beta of 0.48.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.07). LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%. The company had revenue of $70.38 million for the quarter, compared to analysts’ expectations of $71.47 million. During the same quarter in the prior year, the business posted $0.60 EPS. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. As a group, analysts predict that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Thursday, August 20th. LeMaitre Vascular’s payout ratio is presently 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a medical device company focused on the treatment of peripheral vascular disease. The company develops, manufactures and markets products used primarily by vascular surgeons and other specialists in open vascular surgery procedures.

Its product portfolio includes biological and synthetic vascular grafts, carotid shunts, embolectomy and thrombectomy catheters, valvulotomes, vessel closure devices, vascular patches and surgical instruments. These products are designed to support procedures involving the arteries and veins, including the repair, reconstruction and treatment of diseased or obstructed blood vessels.

Founded in 1983 and headquartered in Burlington, Massachusetts, LeMaitre Vascular sells its products through a combination of direct sales personnel and distributors.